Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice

BACKGROUND: Despite considerable progress in the development of anticancer therapies, there is still a high mortality rate caused by cancer relapse and metastasis. Dormant or slow-cycling residual tumor cells are thought to be a source of tumor relapse and metastasis, and are therefore an obstacle t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qing, Zhong, Yong, Wu, Fan, Zhou, Chunxia, Wang, Dongmei, Ma, Wenbo, Zhang, Youhui, Zhang, Shuren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568736/
https://www.ncbi.nlm.nih.gov/pubmed/23270473
http://dx.doi.org/10.1186/1741-7015-10-172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568736/
https://www.ncbi.nlm.nih.gov/pubmed/23270473
http://dx.doi.org/10.1186/1741-7015-10-172

Ejemplares similares